International Multiple Sclerosis Management Practice

What International Multiple Sclerosis Management Practice does

The International Multiple Sclerosis Management Practice (IMSMP) is a private, for-profit specialty medical practice founded in 2006 and headquartered in New York City, dedicated exclusively to the comprehensive management of multiple sclerosis and related neuroimmunologic disorders. The practice operates a single 80,000-square-foot flagship facility in midtown Manhattan (521 West 57th Street) that integrates 10 specialty services under one roof: MS management (neurology), nursing services, physical and occupational therapy, social work services, naturopathic medicine, dietitian services, on-site MRI diagnostics, an 18-pod infusion suite, cognition care, and administrative support. Clinical operations are supported by on-site infrastructure including two Siemens 3-Tesla MRI scanners certified by the American College of Radiology, rehabilitation equipment (Vector bodyweight support system, Cionic Neural Sleeve, Bioness L300, ankle foot orthosis devices), and an 18-pod infusion suite operating 7 days per week - the only MS center in NYC offering weekend infusion appointments. The practice employs 90+ people including 80+ full-time MS specialists (fellowship-trained neurologists, certified MS nurses, therapists, and support staff), serving 4,500+ patients from 56 countries across all MS subtypes and age ranges from 11-98.

IMSMP's business model is primarily fee-for-service clinical care delivery, with insurance coverage varying by physician and plan. The practice generates revenue through neurology consultations, MRI imaging, infusion treatments, physical and occupational therapy, cognitive assessments, and ancillary services. A secondary revenue and reputational stream comes from its partnership with the affiliated Tisch MS Research Center of New York (Tisch MSRCNY), which conducts FDA-approved Phase I and II clinical trials using stem cells to treat progressive MS disability. Distribution is direct-to-patient via phone scheduling and website, with dedicated staff supporting international and out-of-state patient logistics including multilingual support across 19 languages. The practice operates with no disclosed external funding, no parent company, and physician-led ownership under founder Dr. Saud A. Sadiq.

The practice is positioned as the largest independent facility dedicated to MS in the world, distinguishing itself through an integrated bench-to-bedside model where research scientists and clinicians meet multiple times weekly. The clinical team includes Dr. Sadiq (30+ years MS research, 100+ publications, 140+ mentees), Dr. James W. Stark (Associate Medical Director, Director of Clinical Trials), and Dr. Armistead D. Williams III (Associate Medical Director), all named Castle Connolly Top Doctors. IMSMP was recognized as one of Fortune's Best Workplaces in Healthcare 2025, the only specialized clinical practice in New York to receive this designation. The practice also operates the Equality Empowerment Fund (IEEF) scholarship program, awarding $65,000 annually in partnership with Mentoring in Medicine.

Name

International Multiple Sclerosis Management Practice

Legal name

International Multiple Sclerosis Management Practice

Website

https://imsmp.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

IMSMP is a private, NYC-based specialty medical practice founded in 2006 that delivers comprehensive multiple sclerosis care through 10 integrated services under one roof, serving 4,500+ patients from 56 countries with 80+ fellowship-trained MS specialists.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Patient Care Services: Fee-for-service clinical care including neurology consultations, MRI imaging, infusion treatments, physical and occupational therapy, nursing services, cognitive assessments, naturopathic medicine, dietitian services, and social work support. Revenue is generated through patient visits, procedures, and ongoing disease management appointments. Insurance coverage varies by physician and plan, with some in-network coverage and out-of-network options.
2. Clinical Research and Trials: The affiliated Tisch MS Research Center of New York conducts FDA-approved Phase I and II clinical trials using stem cells to treat progressive MS disability, contributing to research programs and therapeutic development.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

IMSMP is a specialized multiple sclerosis medical practice delivering comprehensive, personalized MS care through 10 integrated services under one roof, including neurology consultations, on-site MRI imaging, infusion therapy, physical and occupational therapy, nursing, social work, naturopathic medicine, dietitian services, cognition care, and administrative support. The practice operates on a fee-for-service basis with some in-network insurance options, serving patients from all 50 US states and 56 countries, and is clinically affiliated with the Tisch MS Research Center of New York for translational research and clinical trial access.

Product overview

IMSMP is a comprehensive multiple sclerosis management practice offering an integrated model of clinical care and research. The practice operates as a single unified healthcare delivery platform providing 10 specialty services under one roof: MS Management (neurology care), Nursing Services, Physical and Occupational Therapy, Social Work Services, Naturopathic Medicine, Dietitian Services, On-site MRI diagnostics, Infusion Suite treatments, Cognition Care, and Administrative Support. This integrated approach allows patients to receive coordinated, personalized MS care from diagnosis through ongoing management, with seamless referrals between departments. The practice partners with the Tisch MS Research Center of New York to integrate cutting-edge research with clinical care.

Differentiator

Problem solved

Functional benefit

Products and services

• MS Management
• Nursing Services Clinical nurse specialists, infusion nurses, and research nurses specializing in MS providing comprehensive nursing assessments, symptom management, and inter-department care coordination.
• Physical and Occupational Therapy Licensed physical and occupational therapists providing individualized rehabilitation services including therapeutic exercises, balance training, gait training, fall prevention, and daily task adaptations using state-of-the-art equipment including the Vector bodyweight support system.
• Social Work Services Licensed social workers trained in MS providing 1-on-1 counseling, support groups, disability assistance, government entitlement navigation, and help with Medicare and insurance questions.
• Naturopathic Medicine Holistic wellness services by Dr. Deneb Bates, ND focusing on nutrition, lifestyle, environmental factors, and stress management to complement traditional MS treatment.
• Dietitian Services Registered dietitian Julia Roe provides evidence-based nutrition counseling and personalized meal planning to support MS patients with inflammation reduction, gut health, and overall wellness.
• On-site MRI State-of-the-art MRI Suite with two Siemens 3-Tesla scanners certified by American College of Radiology, allowing immediate doctor review of imaging results.
• Infusion Suite Top-of-the-line outpatient infusion center with 18 private patient pods, oncology-trained nurses, amenities, and 7-day/week availability—the only MS center in NYC with weekend appointments.
• Cognition Care Cognitive assessment and monitoring by Dr. Stavra Romas, a Princeton, Columbia, and Penn State-educated neurologist specializing in evaluation and treatment of cognitive changes in MS.
• Administrative Support Patient coordination services including zero wait times, live phone answering, meticulous record and scheduling coordination, and streamlined insurance interaction.
• Clinical Trials Program FDA-approved Phase I and II clinical trials using stem cells to treat progressive MS disability, conducted at the affiliated Tisch MS Research Center of New York and offered to IMSMP patients.

Quantifiable outcome

• Patient hand functionality improved from 20% to 98% following stem cell treatment program
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Tisch MS Research Center of New YorkcoreStrategic or Co-development Partner · 1 January 2006The Tisch MS Research Center of New York (Tisch MSRCNY) is the research affiliate of IMSMP, together constituting the largest independent facility dedicated to MS in the world. The two institutions opened their doors together in 2006 and operate in close partnership, with doctors and scientists meeting several times per week to discuss clinical and research updates. Tisch MSRCNY has grown into one of the world's premier MS research institutes known for bench-to-bedside innovations and groundbreaking work in regenerative medicine, including the world's first animal model specific to primary progressive MS and first FDA-approved Phase I and II clinical trials using stem cells to treat progressive MS disability.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Mellen Center for Multiple Sclerosis (Cleveland Clinic): Operated within Cleveland Clinic, Mellen Center is one of the largest and oldest dedicated MS treatment and research centers in the US. Comparable to IMSMP as a comprehensive MS specialty destination offering integrated clinical care and research, though embedded within a larger hospital system rather than independent.
• Mayo Clinic Neurology / MS Program: Mayo Clinic operates a major neurology department with significant MS specialization and draws global patients seeking expert opinions. Comparable to IMSMP's integrated research-clinical model and global patient draw, but operates as a much broader multi-specialty incumbent.

Direct peers

• Multiple Sclerosis Comprehensive Care Center (NYU Langone Health): NYU Langone's MS Comprehensive Care Center is a leading academic MS specialty program in the same New York metro market as IMSMP. Directly comparable in offering specialized neurology, infusion, and clinical trial access to MS patients, with similar multidisciplinary care model.
• Partners Multiple Sclerosis Center (Brigham and Women's / Massachusetts General Hospital): Affiliated with Harvard Medical School, Partners MS Center is one of the most prominent academic MS specialty programs in the US. Comparable to IMSMP in offering comprehensive clinical care plus bench-to-bedside MS research and clinical trial access, though embedded in an academic hospital system.
• Johns Hopkins MS Center: Johns Hopkins MS Center is a major academic MS specialty program offering comprehensive care and clinical research. Comparable to IMSMP as a leading multidisciplinary MS destination combining specialty clinical care, infusion, rehabilitation, and clinical trial access.
• Rocky Mountain Multiple Sclerosis Clinic: Independent MS specialty clinic serving patients across the Mountain West region. Directly comparable to IMSMP as an independent physician-owned MS practice with comprehensive care, though smaller and serving a different geography.
• Tisch MS Research Center of New York: The affiliated research institute of IMSMP and the world's first to develop an animal model specific to primary progressive MS. Directly comparable as an MS research and clinical-translation peer, and structurally intertwined with IMSMP via shared leadership and facilities.

Regional players

• Swedish Multiple Sclerosis Center (Seattle): Part of Swedish Health Services in the Pacific Northwest, Swedish MS Center offers comprehensive multidisciplinary MS care including clinical trials. Comparable in care model to IMSMP but operates in a different geography and within a hospital system rather than as an independent practice.

Others

• Accelerated Cure Project for Multiple Sclerosis: Nonprofit organization focused on accelerating MS research through data and bio-sample repositories used by MS researchers including Tisch MSRCNY. Comparable as an MS research ecosystem participant rather than a direct clinical competitor.
• Concussion Legacy Foundation / CLF Research: Specialized research and clinical organization focused on brain disease including neuroimmunology-adjacent work. Comparable to IMSMP's integrated research-clinical model as a thematic peer, though focused on traumatic brain injury rather than MS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCFRn4WYQXVMd_OukplR0V9Q

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Multiple Sclerosis Management Practice